Maesa macrophylla
Maesa macrophylla · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Maesa macrophylla is a significant botanical species known for its diverse array of bioactive secondary metabolites. Phytochemical investigations have revealed that the plant contains essential compounds such as coumarins, flavonoids, saponins, and steroids. Researchers frequently focus on the leaves to isolate these potent chemical constituents for medicinal study. The most common method for accessing these compounds involves the production of ethanolic leaf extracts. Understanding these chemical profiles provides valuable insights into the potential therapeutic applications of this plant.
- Synonyms
- Maesa Tomentosa · Baeobotrys Bogota · 2 more
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Maesa macrophylla is a plant species that is associated with several different botanical names through various taxonomic synonyms. Within scientific literature, it is frequently identified by the synonym Baeobotrys bogota. It is also recognized under the names Baeobotrys macrophylla and Baeobotrys tomentosa. Furthermore, the species has been documented using the synonym Maesa tomentosa in different contexts. These overlapping nomenclatures highlight the complex botanical relationships and historical classification shifts surrounding this plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Maesa macrophylla is a fascinating specimen that belongs to the vast kingdom Plantae. Within this biological kingdom, the plant is specifically classified under the class Equisetopsida. It further descends through the order Ericales, showcasing its complex evolutionary lineage. As a member of the genus Maesa, it maintains a distinct identity among its botanical relatives. Ultimately, this species is nested within the diverse family Primulaceae, completing its taxonomic profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Maesa |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Maesa macrophylla is a plant species with a broad presence across various tropical regions of Asia. Its natural distribution spans the Indian Subcontinent, including the rugged terrain of the East Himalaya and the specific landscapes of Nepal. Beyond the Indian subcontinent, the species also thrives within the Malesia region, particularly throughout Malaya. This wide geographical range highlights the plant's ability to adapt to diverse tropical environments. Consequently, understanding its presence across these distinct territories provides valuable insight into its ecological reach.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Maesa macrophylla is characterized by its distinctive growth form as a shrub. This species is entirely self-supporting, allowing it to maintain its structure within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Maesa macrophylla stands out as a highly potent medicinal plant sourced from the Darjeeling Himalayas due to its significant cytotoxic properties. Detailed phytochemical analysis has revealed that this species contains a diverse array of biologically active compounds. Specifically, the plant is known to contain coumarins, flavonoids, and tannins. Additionally, the presence of saponins and steroids contributes to its complex chemical profile. These multiple constituents make the plant a promising subject for further exploration in the development of anticancer treatments.
Conditions
Maesa macrophylla demonstrates significant anticancer potential through its ability to treat several human cancer cell lines. Specifically, the ethanolic leaf extracts of this plant effectively treat the human breast adenocarcinoma cell line, known as MCF 7. It also shows potent cytotoxic activity in treating the human cervix adenocarcinoma cell line, referred to as HeLa. Additionally, the plant's extracts are tested against and act upon the human hepatocarcinoma cell line, HepG2. These biological interactions highlight the plant's capacity to inhibit the growth of multiple types of human cancer cells.
Preparations
Maesa macrophylla is prepared as ethanolic leaf extracts to investigate its potential anticancer properties. These specific extracts were tested for cytotoxicity against various human cancer cell lines, including MCF 7, HepG2, and HeLa. Through this preparation, the plant demonstrated significant growth inhibition, particularly against the HeLa and MCF7 cell lines. Phytochemical analysis of the prepared extracts revealed the presence of bioactive compounds such as flavonoids, tannins, and steroids. This extraction method proved effective in identifying the potent medicinal constituents within the plant.
Parts used
Maesa macrophylla stands out as a significant medicinal plant within the diverse botanical landscape of the Darjeeling Himalayas. Recent studies have focused specifically on the ethanolic leaf extracts of this species to evaluate their potential in cancer treatment. Research demonstrates that the leaves of Maesa macrophylla exhibit potent cytotoxic activity against human breast adenocarcinoma and cervix adenocarcinoma cell lines. Phytochemical analysis of these leaf components reveals a rich profile of bioactive compounds, including flavonoids, tannins, and steroids. These findings suggest that the plant's leaves hold immense promise for the discovery of new anticancer constituents.